72 related articles for article (PubMed ID: 2114043)
21. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
22. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
23. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin.
Mannucci L; Gerometta PS; Mussoni L; Antona C; Parolari A; Salvi L; Biglioli P; Tremoli E
Thromb Haemost; 1995 Mar; 73(3):356-61. PubMed ID: 7545317
[TBL] [Abstract][Full Text] [Related]
24. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
25. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
Spannagl M; Dooijewaard G; Dietrich W; Kluft C
Thromb Haemost; 1995 May; 73(5):825-8. PubMed ID: 7482410
[TBL] [Abstract][Full Text] [Related]
26. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
[TBL] [Abstract][Full Text] [Related]
27. Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding.
Suehiro S; Shibata T; Sasaki Y; Hattori K; Kumano H; Hosono M; Kinoshita H
Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):225-9. PubMed ID: 10508946
[TBL] [Abstract][Full Text] [Related]
28. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
[TBL] [Abstract][Full Text] [Related]
29. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
30. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
Tsuji K; Eguchi Y; Kodama M
J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
[TBL] [Abstract][Full Text] [Related]
31. Fibrin-dependent fibrinolytic activity during extracorporeal circulation.
Giuliani R; Szwarcer E; Martinez Aquino E; Palumbo G
Thromb Res; 1991 Feb; 61(4):369-73. PubMed ID: 1905846
[TBL] [Abstract][Full Text] [Related]
32. Pericardial trauma and adhesions in relation to reoperative cardiac surgery.
Nkere UU; Whawell SA; Sarraf CE; Schofield JB; Thompson JN; Taylor KM
Thorac Cardiovasc Surg; 1995 Dec; 43(6):338-46. PubMed ID: 8775859
[TBL] [Abstract][Full Text] [Related]
33. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
Ray MJ; Marsh NA; Hawson GA
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
[TBL] [Abstract][Full Text] [Related]
34. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.
Páramo JA; Rifón J; Llorens R; Casares J; Paloma MJ; Rocha E
Haemostasis; 1991; 21(1):58-64. PubMed ID: 1907591
[TBL] [Abstract][Full Text] [Related]
35. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.
Stibbe J; Kluft C; Brommer EJ; Gomes M; de Jong DS; Nauta J
Eur J Clin Invest; 1984 Oct; 14(5):375-82. PubMed ID: 6437836
[TBL] [Abstract][Full Text] [Related]
36. [Tissue plasminogen activator, its inhibitor and other factors of the blood fibrinolytic system in stable coronary heart disease].
Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN
Kardiologiia; 1992 Feb; 32(2):9-12. PubMed ID: 1527946
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of fibrinolysis parameters during myocardial revascularization according to type of procedure.
Zivković M; Brkić K; Nikić N; Hasperger D; Juricek J; Husedzinović I; Sutlić Z
Clin Chem Lab Med; 2005; 43(1):43-8. PubMed ID: 15653441
[TBL] [Abstract][Full Text] [Related]
38. D-Dimer formation during cardiac and noncardiac thoracic surgery.
Whitten CW; Greilich PE; Ivy R; Burkhardt D; Allison PM
Anesth Analg; 1999 Jun; 88(6):1226-31. PubMed ID: 10357323
[TBL] [Abstract][Full Text] [Related]
39. Biological mechanisms and individual variation in fibrinolysis after major trauma.
Coats TJ; Morsy M
Emerg Med J; 2020 Mar; 37(3):135-140. PubMed ID: 32001608
[TBL] [Abstract][Full Text] [Related]
40. The effect of methylprednisolone treatment on fibrinolysis, thecoagulation system, and blood loss in cardiac surgery.
Ebrahimi L; Kheirandish M; Foroughi M
Turk J Med Sci; 2016 Dec; 46(6):1645-1654. PubMed ID: 28081351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
